Company Announcements

Clarification regarding the coupon payment

Source: RNS
RNS Number : 4875F
Evraz Plc
21 March 2022

Clarification regarding the coupon payment for the 5.375% Eurobond 2023 payable on 21 March 2022


21 March 2022 - EVRAZ plc (the "Issuer", the "Company") informs that it has made a regular coupon payment due on 21 March 2022 under outstanding principal amount of US$704,099,000.00 Notes due 2023 (the "2023 Notes"). However, as per communication from the Bank of New York Mellon, London Branch (the "Principal Paying Agent"), the amount is not settled up until today and remains blocked for compliance at the correspondent bank, Societe Generale New York.   

Amid the unprecedented degree of uncertainty and due to the lack of feedback from relevant financial counterparties, regulators and advisors, in an effort to protect the rights of the Noteholders, on 16 March 2022, 2 business days prior to the deadline, the Issuer made a payment to the relevant account with the Principal Paying Agent in the amount of US$18,922,660.63 to fund a coupon payment under its 2023 Notes. The Issuer received swift confirmation for this payment.

The payment was stopped for compliance by the correspondent bank, Societe Generale New York. Over the course of several days, the Company put all its efforts to release the payment from correspondent bank to specified account of the Principal Paying Agent, providing all requested information concerning this payment, its economic substance and nature.

At the time of the release, the Issuer received a confirmation that by close of business 18 March 2022, the Principal Paying Agent has not received the payment. Based on this confirmation, the Issuer notified the BNY Mellon Corporate Trustee Services Limited (the "Trustee") about the Potential Event of Default as defined in the Trust deed of 2023 Notes.

The Company understands that the situation has its roots in the recently emerged uncertainties upon decision of the HM Treasury, Office of Financial Sanctions Implementation ("OFSI") to include one of Company's shareholders Roman Abramovich, owning 28.64% stake, in the extended sanctions list.

The Company continues to stand on the position that Roman Abramovich does not have effective control of the Company. This position was outlined in the press release published on 10 March 2022.

Furthermore, the Company believes that it is neither designated nor sanctioned. To provide comfort and certainty to all its counterparties, the Company has sought clarity and confirmation from Foreign, Commonwealth and Development Office (the "FCDO") and OFSI. Their responses are still pending. Separately, given the urgency of the matter, the Company has also approached OFSI and Sanctions Task Force of FCDO to provide clarifications specifically regarding the coupon payment.

The Company would like to highlight that apart from malfunction of financial infrastructure, there are no reasons for a Potential Event of Default. The Issuer has sufficient liquidity to complete the coupon payments. The Company is fully committed to put all efforts to resolve the situation as soon as possible with release of coupon payment under the 2023 Notes and fulfil its payment obligations due on 4 April 2022 under its $700,000,000.00 Notes due 2024 (the "2024 Notes").




For further information:



Investor Relations:

+7 495 232 1370

+44 207 290 1095


Media Relations:

+7 495 937 6871

+44 207 290 1096




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.